Collaboration is no longer optional in today’s diagnostic landscape – it’s essential. As laboratories face rising expectations, partnerships between purpose-built platforms are driving the next generation of lab innovation, especially when it comes to lab information systems (LIS).
One such collaboration is the powerful integration between LabOS & PreciseMDX, designed to streamline lab operations while elevating the patient experience. At the center of this effort is Mark Dorner, a key figure at PreciseMDX and a passionate advocate for digital transformation in healthcare.
In this interview, Mark shares his perspective on the evolving needs of modern labs, what sparked the partnership with LabOS, and how working together is helping labs stay ahead in a rapidly changing environment.
1. To start off, tell us briefly who you are and what your company does.
I’m Mark Dorner, Co-Founder and CEO of PreciseMDX, a digital health company redefining the laboratory diagnostics journey through seamless, patient-first digital infrastructure. We provide a fully integrated platform that bridges the gap between clinical operations and user experience. Our mission is to streamline the diagnostic process from end to end – empowering labs to scale, reduce complexity, and better engage patients and providers.
With a leadership team rooted in healthcare innovation, we’re passionate about solving the practical and technical challenges labs face today.
2. What problem are you solving in the healthcare and diagnostics ecosystem?
Diagnostics has long suffered from disconnected systems, paper-heavy workflows, and inconsistent patient experiences. Our platform solves these challenges by providing labs with a digital foundation that eliminates bottlenecks and increases transparency.
A standout example is our AI engine capable of reading and interpreting handwritten lab orders – a longstanding pain point in the industry. This breakthrough drastically reduces manual data entry, minimizes errors, and accelerates test processing. In short, we’re bringing automation and intelligence into places where inefficiencies used to thrive.
3. PreciseMDX is focused on the patient/clinician experience. What are the most pressing needs you’re addressing in digital diagnostics?
Clinicians and patients alike want faster, clearer, and more user-friendly diagnostic experiences. That includes intuitive ordering, real-time tracking, and easy-to-understand results. However, a major friction point has always been handwritten orders, which can lead to delays or misinterpretations.
Our AI-driven document recognition reads these handwritten forms, extracts relevant data, and instantly populates it into the system, turning a historically manual task into a digital one. It’s one of many ways we’re enhancing access, accuracy, and speed at every step.
4. Your platform emphasizes real-time communication and engagement – how does this impact the clinical and patient experience?
Real-time communication closes critical gaps in diagnostics. Patients receive timely updates via SMS, email, or portal notifications, while clinicians can track order progress and access results in real time. This responsiveness reduces anxiety, improves engagement, and ensures that diagnostic decisions happen without delay. And when paired with our AI tools – like the ability to digitally process handwritten test requests – we’re helping labs turn around results faster and with fewer errors, improving outcomes across the board.
5. How did the LabOS & PreciseMDX partnership start, and what sparked the initial collaboration?
We saw an opportunity to bring together two best-in-class systems – LabOS for operational excellence in LIS, and PreciseMDX for digital transformation on the front end. Our teams shared a commitment to modernizing the lab landscape, and it was clear from the start that our technologies would be more powerful together.
The integration enables labs to operate more efficiently, while also adopting cutting-edge tools like AI-based handwritten order reading that simplify workflows from the moment a requisition arrives.
6. What is the value of this integration to your shared customers – labs, clinicians, and patients?
The value of the LabOS & PreciseMDX partnership is exponential. Labs benefit from end-to-end automation, reduced labor costs, and accelerated throughput. Clinicians can order tests and receive results in a fraction of the time, with fewer administrative hurdles. Furthermore, patients enjoy a modern, digital experience that builds trust and keeps them engaged. And with our AI recognizing handwritten lab orders, labs can now process even legacy workflows with speed and precision – unlocking value from both digital and analog channels.
This integration creates a comprehensive ecosystem for diagnostics that is both high-tech and highly human.
7. What’s next for this partnership? Any exciting developments or goals you’re aiming for together?
We’re continuing to expand our joint capabilities, especially around AI and automation. That includes enhancing our handwritten order recognition engine with more languages and formats, for instance. Additionally, it means integrating with imaging and biometrics, and building predictive models that guide decision-making before test results even arrive.
With this LabOS & PreciseMDX partnership, we’re setting a new standard for digital diagnostics – where manual inputs become automated, data flows effortlessly, and patients are always in the loop. The future is intelligent, and we’re excited to lead the way.
DISCOVER MORE LIS POSSIBILITIES
